Skip to main content
SpringerLink
Log in

Use a stepwise approach when selecting treatment for cutaneous sarcoidosis

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Treatment of cutaneous sarcoidosis is associated with substantial improvements in the condition in clinical practice; however, robust clinical trial data regarding the efficacy of various treatments are lacking. Topical agents should be considered first-line options in all patients, with the addition of systemic immunomodulators and/or immunosuppressants if required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wanat KA, Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol. 2014;15(4):283–97.

    Article  PubMed  Google Scholar 

  2. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med. 2007;28(1):22–35.

    Article  PubMed  Google Scholar 

  3. Rybicki BA, Maliarik MJ, Major M, et al. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect. 1998;13(3):166–73.

    CAS  PubMed  Google Scholar 

  4. Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA. 2011;305(4):391–9.

    Article  CAS  PubMed  Google Scholar 

  5. Haimovic A, Sanchez M, Judson MA, et al. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 2012;66(5):699. e1–18.

  6. Haimovic A, Sanchez M, Judson MA, et al. Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease. J Am Acad Dermatol. 2012;66(5):719. e1–10.

  7. Marcoval J, Mañá J, Rubio M. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol. 2011;36(7):734–44.

    Article  Google Scholar 

  8. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol. 1992;72(1):69–71.

    CAS  PubMed  Google Scholar 

  9. Callen JP. Intralesional corticosteroids. J Am Acad Dermatol. 1981;4(2):149–51.

    Article  CAS  PubMed  Google Scholar 

  10. Katoh N, Mihara H, Yasuno H. Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol. 2002;147(1):154–6.

    Article  CAS  PubMed  Google Scholar 

  11. Penrose C, Mercer SE, Shim-Chang H. Photodynamic therapy for the treatment of cutaneous sarcoidosis. J Am Acad Dermatol. 2011;65(1):e12–4.

    Article  PubMed  Google Scholar 

  12. Kondo C, Watanabe D, Nakaseko H, et al. Photodynamic therapy for recurrent sarcoid flexor tenosynovitis of the finger. J Am Acad Dermatol. 2006;55(5 Suppl):S99–101.

    Article  PubMed  Google Scholar 

  13. Holzmann RD, Astner S, Forschner T, et al. Scar sarcoidosis in a child: case report of successful treatment with the pulsed dye laser. Dermatol Surg. 2008;34(3):393–6.

    CAS  PubMed  Google Scholar 

  14. Green JJ, Lawrence N, Heymann WR. Generalized ulcerative sarcoidosis induced by therapy with the flashlamp-pumped pulsed dye laser. Arch Dermatol. 2001;137(4):507–8.

    CAS  PubMed  Google Scholar 

  15. Roos S, Raulin C, Ockenfels HM, et al. Successful treatment of cutaneous sarcoidosis lesions with the flashlamp pumpled pulsed dye laser: a case report. Dermatol Surg. 2009;35(7):1139–40.

    Article  CAS  PubMed  Google Scholar 

  16. Gleeson CM, Morar N, Staveley I, et al. Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A. Br J Dermatol. 2011;164(4):892–4.

    Article  CAS  PubMed  Google Scholar 

  17. Modi S, Rosen T. Micropapular cutaneous sarcoidosis: case series successfully managed with hydroxychloroquine sulfate. Cutis. 2008;81(4):351–4.

    PubMed  Google Scholar 

  18. Zic JA, Horowitz DH, Arzubiaga C, et al. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature. Arch Dermatol. 1991;127(7):1034–40.

    Article  CAS  PubMed  Google Scholar 

  19. Bachelez H, Senet P, Cadranet J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001;137(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  20. Park MK, Fontana JR, Babaali H, et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26(2):121–31.

    CAS  PubMed Central  PubMed  Google Scholar 

  21. Baughman RP, Judson MA, Ingledue R, et al. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. Arch Dermatol. 2012;148(2):262–4.

    Article  CAS  PubMed  Google Scholar 

  22. Badgwell C, Rosen T. Cutaneous sarcoidosis therapy updated. J Am Acad Dermatol. 2007;56(1):69–83.

    Article  PubMed  Google Scholar 

  23. Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol. 2012;8(1):95–103.

    Article  PubMed  Google Scholar 

  24. Fazzi P, Manni E, Cristofani R, et al. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids. Biomed Pharmacother. 2012;66(4):300–4.

    Article  CAS  PubMed  Google Scholar 

  25. Tu J, Chan J. Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease. Australas J Dermatol. 2013. doi:10.1111/ajd.12056.

  26. Thielen AM, Barde C, Saurat JH, et al. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists. Dermatology. 2009;219(1):59–62.

    Article  CAS  PubMed  Google Scholar 

  27. Stagaki E, Mountford WK, Lackland DT, et al. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest. 2009;135(2):468–76.

    Article  PubMed  Google Scholar 

  28. Pariser RJ, Paul J, Hirano S, et al. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol. 2013;68(5):765–73.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

This article was adapted from the American Journal of Clinical Dermatology 2014;15(4):283–97 [1] by salaried/contracted employees of Adis/Springer, and was not supported by any external funding.

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Use a stepwise approach when selecting treatment for cutaneous sarcoidosis. Drugs Ther Perspect 31, 23–26 (2015). https://doi.org/10.1007/s40267-014-0168-7

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-014-0168-7

    Keywords

    Search

    Navigation